2018 Fulbright NZ scholarships announced
16 January 2018
Fulbright New Zealand recently announced its 2018 scholarship grant winners, with two Maurice Wilkins Centre investigators among the select group of recipients.
Lung cancer drug poised for global approval, says MWC investigator
11 December 2017
Dacomitinib, an irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor developed in collaboration with Pfizer by researchers led by MWC Associate Investigator Dr. Jeff Smaill, has shown significant efficacy in the treatment of patients with non-small-...